Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart
Bloomberg
Fri, 08/21/15 - 05:24 pm
Merck
Januvia
Janumet
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
The 2013 Merck-Pfizer Diabetes Deal Now Looks Very Savvy
Forbes
Thu, 08/20/15 - 03:14 pm
Merck
Pfizer
diabetes
Jardiance
Januvia
ertugliflozin
Eli Lilly
Will pricey new drug classes take the wind out of diabetes launches?
Fierce Pharma Marketing
Wed, 08/19/15 - 10:01 am
diabetes
Novo Nordisk
Eli Lilly
Boehringer Ingelheim
Sanofi
Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial
Bizjournals.com
Tue, 08/18/15 - 09:26 pm
Intarcia
Merck
diabetes
type 2 diabetes
devices
ITCA 650
Januvia
Takeda Actos settlement seems shaky as plaintiffs give it the sniff test
Fierce Pharma
Fri, 08/14/15 - 11:17 am
Takeda
Actos
diabetes
bladder cancer
Biggest Insulin Maker May Build Diabetes Drug Plant in U.S.
Bloomberg
Fri, 08/14/15 - 09:18 am
Novo Nordisk
drug manufacturing
diabetes
insulin
MannKind Cheered Despite Lower Afrezza Shipments
24/7 Wall St
Mon, 08/10/15 - 09:49 am
Afrezza
diabetes
insulin
MannKind
Sanofi
inhaled insulin
Sanofi deepens its Evotec ties with a $330M diabetes deal
Fierce Biotech
Sat, 08/8/15 - 01:22 pm
Sanofi
Evotec
diabetes
cell replacement therapy
Novo Nordisk says any tussle with Sanofi's Toujeo will come down to formulary access
Medical Marketing and Media
Fri, 08/7/15 - 08:43 am
Sanofi
Novo Nordisk
Toujeo
formulary
Tresiba
insulin
diabetes
Sanofi and MannKind launch Afrezza DTC ad campaign in stealth mode
Fierce Pharma Marketing
Mon, 08/3/15 - 04:50 pm
Sanofi
MannKind
DTC
Afrezza
diabetes
inhaled insulin
insulin
Afrezza sales still underperforming, but MannKind remains optimistic
BioPharma Dive
Fri, 07/31/15 - 11:06 am
Afrezza
diabetes
insulin
inhaled insulin
MannKind
Sanofi
MannKind Afrezza Sales Underwhelming Again, Sanofi Reports
TheStreet.com
Thu, 07/30/15 - 10:28 am
MannKind
Afrezza
Sanofi
diabetes
insulin
inhaled insulin
Sanofi's diabetes combo clears a clinical hurdle in a race with Novo Nordisk
Fierce Biotech
Wed, 07/29/15 - 09:51 pm
Sanofi
diabetes
type 2 diabetes
LixiLan
Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes
Yahoo
Wed, 07/15/15 - 09:20 am
Eli Lilly
diabetes
Android
smartphones
mobile apps
Novo Nordisk looks past blockbuster Victoza with PhIII success for weekly GLP-1 med
Fierce Pharma Marketing
Tue, 07/14/15 - 10:41 am
Novo Nordisk
diabetes
Victoza
semaglutide
GLP-1 agonist
Novo Nordisk's new GLP-1 diabetes drug hits goal in trial
Yahoo/Reuters
Sat, 07/11/15 - 10:25 am
Novo Nordisk
GLP-1 agonist
diabetes
semaglutide
Will India Issue a Compulsory License for an AstraZeneca Diabetes Pill?
WSJ Pharmalot
Thu, 07/9/15 - 10:28 am
India
diabetes
AstraZeneca
Gleevec
SC high court further reduces penalty in drug marketing case
Yahoo/AP
Thu, 07/9/15 - 10:07 am
JNJ
Janssen
South Carolina
diabetes
Risperdal
antipsychotics
Oramed's Quick Road to Market as Global Leader of Oral Insulin Capsule
Yahoo
Wed, 07/8/15 - 09:16 am
Oramed
insulin
diabetes
Sanofi, Gilead get boosts in Japan with new Lantus & Harvoni approvals
BioPharma Dive
Tue, 07/7/15 - 10:51 am
Sanofi
Gilead Sciences
Japan
Lantus
Harvoni
diabetes
hepatitis C
Pages
« first
‹ previous
…
48
49
50
51
52
53
54
55
56
…
next ›
last »